Background: Compartment syndrome of the hand is a rare and devastating complication of peripheral intravenous extravasation. With changes in critical care research, vasoactive medications are now more frequently administered through peripheral lines in the acute setting. Methods: We present the case of a patient diagnosed with compartment syndrome of the hand secondary to phenylephrine extravasation in the setting of hypovolemic shock. Results: The use of fasciotomy compartment release and intraoperative phentolamine resulted in significant improvement in tissue perfusion postoperatively. Conclusion: With incraesed incidence of peripherally administered vasoactive medications, the hand surgeon should be aware of potential complications and treatment of compartment syndrome with urgent fasciotomy and phentolamine administration.
Background: Compartment syndrome of the hand is a rare and devastating complication of peripheral intravenous extravasation. With changes in critical care research, vasoactive medications are now more frequently administered through peripheral lines in the acute setting. Methods: We present the case of a patient diagnosed with compartment syndrome of the hand secondary to phenylephrine extravasation in the setting of hypovolemic shock. Results: The use of fasciotomy compartment release and intraoperative phentolamine resulted in significant improvement in tissue perfusion postoperatively. Conclusion: With incraesed incidence of peripherally administered vasoactive medications, the hand surgeon should be aware of potential complications and treatment of compartment syndrome with urgent fasciotomy and phentolamine administration.
Entities:
Keywords:
fasciotomy; hand compartment syndrome; phentolamine; phenylephrine; vasoactive extravasation
Authors: Jose Cardenas-Garcia; Karen F Schaub; Yuly G Belchikov; Mangala Narasimhan; Seth J Koenig; Paul H Mayo Journal: J Hosp Med Date: 2015-05-26 Impact factor: 2.960
Authors: Paul M Reynolds; Robert MacLaren; Scott W Mueller; Douglas N Fish; Tyree H Kiser Journal: Pharmacotherapy Date: 2014-01-13 Impact factor: 4.705